Recent Advances in the Application of Machine Learning Models in Metabolic Dysfunction–Associated Steatotic Liver Disease

Documenti analoghi

• Agile 3+ Index Is Independently Associated With Cardiovascular Diseases in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease: Analysis of NHANES 2017–2020
  di: Yan Li, et al.
  Pubblicazione: (2026)
• Earlier Menopause and Risk of Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Global Cohort Study
  di: Joshua Stokar, et al.
  Pubblicazione: (2026)
• Machine Learning‐Assisted Analysis of Sublingual Microcirculatory Dysfunction for Early Cardiovascular Risk Evaluation and Cardiovascular‐Kidney‐Metabolic Syndrome Stage in Patients With Type 2 Diabetes Mellitus
  di: Wei Liu, et al.
  Pubblicazione: (2024)
• Current Progress and Challenges in the Development of Pharmacotherapy for Metabolic Dysfunction‐Associated Steatohepatitis
  di: Yang Zhi, et al.
  Pubblicazione: (2024)
• Integrating Artificial Intelligence in the Diagnosis and Management of Metabolic Syndrome: A Comprehensive Review
  di: Jingjing Liu, et al.
  Pubblicazione: (2025)